Cargando…

Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD

COVID-19 is still a global public health concern, and the SARS-CoV-2 mutations require more effective antiviral agents. In this study, the antiviral entry activity of thirty-one flavonoids was systematically evaluated by a SARS-CoV-2 pseudovirus model. Twenty-four flavonoids exhibited antiviral entr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Jie-Ru, Liu, Jiazheng, Fu, Lu, Shu, Tong, Yang, Lingzhi, Zhang, Xueji, Jiang, Zhi-Hong, Bai, Li-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862759/ https://www.ncbi.nlm.nih.gov/pubmed/36680200 http://dx.doi.org/10.3390/v15010160

Ejemplares similares

VE607 stabilizes SARS-CoV-2 Spike in the “RBD-up” conformation and inhibits viral entry
por: Ding, Shilei, et al.
Publicado: (2022)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor
por: Kim, Young Soo, et al.
Publicado: (2021)

Evaluation of flavonoids as potential inhibitors of the SARS-CoV-2 main protease and spike RBD: Molecular docking, ADMET evaluation and molecular dynamics simulations
por: Hadni, Hanine, et al.
Publicado: (2022)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs
por: Manček‐Keber, Mateja, et al.
Publicado: (2021)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
por: Wang, Xiaoning, et al.
Publicado: (2021)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
por: De March, Matteo, et al.
Publicado: (2022)

Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
por: Passariello, Margherita, et al.
Publicado: (2021)

SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
por: Miao, Lu, et al.
Publicado: (2023)

Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein
por: Vetráková, A., et al.
Publicado: (2023)

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response
por: Lainšček, Duško, et al.
Publicado: (2021)

Impaired Humoral Immunity Identified in Inactivated SARS-CoV-2 Vaccine Recipients without Anti-Spike RBD Antibodies
por: Sun, Ting, et al.
Publicado: (2023)

Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development
por: Zhou, Yuchen, et al.
Publicado: (2023)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
por: Semenov, Valentin A., et al.
Publicado: (2022)

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
por: Shah, Masaud, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

Comparative structural analyses of selected spike protein-RBD mutations in SARS-CoV-2 lineages
por: Roy, Urmi
Publicado: (2021)

Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
por: da Costa, Clauber Henrique Souza, et al.
Publicado: (2022)

Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein
por: Chen, Yu-Lei, et al.
Publicado: (2022)

Improved Expression of SARS-CoV-2 Spike RBD Using the Insect Cell-Baculovirus System
por: Poodts, Joaquín, et al.
Publicado: (2022)

Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022)

HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19
por: Zhang, Liqun, et al.
Publicado: (2022)

Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells
por: Zhang, Liqun, et al.
Publicado: (2021)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
por: Budhraja, Anshul, et al.
Publicado: (2021)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
por: Cao, Wenpeng, et al.
Publicado: (2021)

A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
por: Fernandez-Fuentes, Narcis, et al.
Publicado: (2021)

Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis
por: Passariello, Margherita, et al.
Publicado: (2021)

Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern
por: Kim, Seonghan, et al.
Publicado: (2021)

Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern
por: Kim, Seonghan, et al.
Publicado: (2022)

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
por: Gelbach, Adrianne L., et al.
Publicado: (2022)

Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein
por: Fan, Youpeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q021qjb8sog5ghme4729hg9p0i